BioAtla (BCAB) Current Assets (2020 - 2026)

BioAtla (BCAB) has reported Current Assets for 7 consecutive years, with $4.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets fell 79.34% year-over-year to $4.3 million; the trailing twelve-month figure through Jun 2026 stood at $4.3 million (down 79.34% YoY), and the FY2025 full-year result was $8.0 million, down 84.36% from the prior year.
• Current Assets rose to $4.3 million in Q2 2026 per BCAB's latest filing, from $3.1 million in the prior quarter.
• Across five years, Current Assets topped out at $224.0 million in Q1 2022 and bottomed at $3.1 million in Q1 2026.
• Historically, Current Assets has averaged $101.2 million across 5 years, with a median of $76.5 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Current Assets fell 0.25% in 2022, then plunged 91.76% in 2026.
• Over 5 years, Current Assets stood at $220.4 million in 2022, then tumbled by 47.19% to $116.4 million in 2023, then plunged by 55.99% to $51.2 million in 2024, then slumped by 84.36% to $8.0 million in 2025, then sank by 46.86% to $4.3 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $4.3 million, $3.1 million, and $8.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.